Nancy Pryer, Ph.D.
Chief Development Officer
Nancy Pryer, Ph.D. is Chief Development Officer at Nurix. She is a translational sciences leader with extensive experience leading the discovery and advancement of novel therapeutic candidates to exploratory clinical development. Prior to joining Nurix, Dr. Pryer served as Vice President of Translational Sciences at BioMarin Pharmaceutical where she led the company’s significant efforts in biomarker discovery, bioanalytical sciences, immunogenicity assessment and clinical pharmacology. Prior to joining BioMarin, Dr. Pryer held leadership roles in oncology drug discovery and translational development at Novartis Institutes for Biomedical Research, Raven, SUGEN and Onyx Pharmaceuticals. Dr. Pryer received her Ph.D. in Biology from the University of North Carolina, Chapel Hill, and completed post-doctoral work at the University of California, Berkeley. She holds a B.S. in Zoology from the University of California, Davis.